CORINDUS VASCULAR ROBOTICS, INC
CVRS
CVRS was delisted on the 28th of October, 2019.
39 hedge funds and large institutions have $146M invested in CORINDUS VASCULAR ROBOTICS, INC in 2015 Q2 according to their latest regulatory filings, with 39 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
35.57% more ownership
Funds ownership: 0% → 35.57% (+36%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
+$85.2M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$44M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$26.9M |
| 4 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$8.55M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.55M |
Top Sellers
CVRS Hedge Fund Activity: Q2 2015 in Review
39 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in CORINDUS VASCULAR ROBOTICS, INC (CVRS) for Q2 2015, worth a combined $146M.
Buyers outnumbered sellers: 39 funds opened new CVRS positions and 0 closed out — a net gain of 39 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was HealthCor Management, opening a new position worth an estimated $85.2M.
- 39 institutional investors held CORINDUS VASCULAR ROBOTICS, INC (CVRS) as of Q2 2015, up from 0 in Q1 2015.
- Funds reported $146M of CORINDUS VASCULAR ROBOTICS, INC stock for Q2 2015.
- 39 funds opened new CORINDUS VASCULAR ROBOTICS, INC positions in Q2 2015 and 0 closed out, a net change of +39 holders.
- The largest CORINDUS VASCULAR ROBOTICS, INC buyer in Q2 2015 was HealthCor Management, an estimated $85.2M added.
Based on aggregated 13F filings for Q2 2015.